Medical/Pharmaceuticals
Ascletis Announces First Patient Dosed in the Phase III Clinical Trial of FASN Inhibitor ASC40 Combined with Bevacizumab for Treatment of Recurrent Glioblastoma
HANGZHOU and SHAOXING, China, Jan. 23, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) today announces the dosing of the first patient in the Phase III registration clinical trial of ASC40 combined with bevacizumab for treatment of recurrent glioblastoma (rGBM). ASC40 is an oral, sele...
2022-01-23 18:35
3423
Innovent and Eli Lilly and Company Announced Final Clinical Results and Biomarker Analysis of Phase Ib Study of TYVYT® (Sintilimab Injection) Plus Bevacizumab Biosimilar Injection for Advanced Hepatocellular Carcinoma at ASCO GI Annual Meeting 2022
SAN FRANCISCO and SUZHOU, China, Jan. 22, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major disea...
2022-01-22 08:00
7828
Swiss Pharma Company - IDEOGEN takes over Special Access Program for BELEODAQ® (belinostat)
HURDEN, Switzerland, Jan. 22, 2022 /PRNewswire/ -- IDEOGEN GROUP, Managed Access division, takes over Special Access Program for BELEODAQ® (belinostat) in Europe, Middle East, North Africa, Russia, and CIS. BELEODAQ® is a prescription medicine used to treat patients with a rare form of blood canc...
2022-01-22 04:24
3929
Sihuan Pharmaceutical (0460.HK): Establishment of Joint Venture with Bluepha Co., Ltd.
HONG KONG, Jan. 21, 2022 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Co., Ltd. (the "Company" or "Sihuan Pharmaceutical", together with its subsidiaries, collectively referred to as the "Group:" Hong Kong Stock Exchange Stock Code: 0460) is pleased to announce thatBeijing MeiYan KongJian...
2022-01-21 11:12
5021
Hinova Announces First Patient Dosed in a Phase I Clinical Trial of HP518, an orally bioavailable Chimeric Degrader targeting Androgen Receptor for Prostate Cancer Treatment
MELBOURNE, Australia, Jan. 21, 2022 /PRNewswire/ -- Hinova Pharmaceuticals Inc., a clinical-stage biopharmaceutical company focused on developing novel therapeutics for cancers and metabolic diseases through targeted protein degradation technologies, announced that the first patient with metastat...
2022-01-21 05:30
2070
Suvoda Exceeds 2021 Targets; Poised for Continued Growth Supporting Complex Clinical Trials in 2022
Surpasses 900 trials across 65 countries, expands leadership team and product offerings, and posts another year of 30% growth, all while maintaining an exceptional performance level. PHILADELPHIA, Jan. 20, 2022 /PRNewswire/ -- Suvoda, LLC, a global clinical trial technology company that speciali...
2022-01-20 23:05
2202
Bridget Johnson Joins CSafe Global as Senior Vice President of Marketing
CSafe Global makes strategic addition to its senior leadership team bringing Bridget Johnson on board as the SVP of Marketing DAYTON, Ohio, Jan. 20, 2022 /PRNewswire/ -- CSafe Global, the innovation leader in temperature-controlled container solutions for the transport of life-enhancing pharma...
2022-01-20 21:15
3170
Victor Papamoniodis Joins Medison Pharma as VP International Markets
ZUG, Switzerland, Jan. 20, 2022 /PRNewswire/ -- Medison
2022-01-20 20:35
2155
Sputnik V demonstrates strong protection against Omicron variant, with over 2 times higher virus neutralizing activity compared to the Pfizer vaccine according to a unique independent comparative study conducted by the Spallanzani Institute in Italy
Previous studies also demonstrated additional significant strengthening of protection against Omicron by Sputnik Light booster, which can also be a universal booster to other vaccines to strengthen and lengthen their protection against Omicron. MOSCOW, Jan. 20, 2022 /PRNewswire/ -- * A uniqu...
2022-01-20 19:00
4988
Successful Completion of First Patient Implantation of MINI WELL® and MINI WELL TORIC® Extended Depth-of-Focus IOLs in China Announced by Affamed Technologies, Joint Venture between AffaMed Therapeutics and SIFI
CATANIA, Italy, Jan. 20, 2022 /PRNewswire/ -- SIFI, a leading international ophthalmic company headquartered inItaly, is pleased to divulge the successful completion of the first patient implantation of MINI WELL® and MINI WELL TORIC® IOLs inChina, announced via Affamed Technologies, Joint Ventur...
2022-01-20 16:00
2677
Glenmark Specialty S.A. and Lotus International Pte. Ltd. enter into Exclusive Licensing Agreement for commercializing Ryaltris (TM) Nasal Spray in Singapore, Hong Kong and Vietnam
* Under the terms of the agreement, Glenmark will be responsible for the manufacture and supply of Ryaltris™, while Lotus International Pte. Ltd. will be responsible for the commercialization of Ryaltris™ (subject to receipt of regulatory approvals) across these markets. * Glenmark will recei...
2022-01-20 15:48
1949
Wonju Medical Industry Techno Valley Supports Overseas Market Entry of Medical Devices Through Participation of Dubai Arab Health 2022
SEOUL, South Korea, Jan. 20, 2022 /PRNewswire/ -- Wonju Medical Industry Techno Valley (PresidentKim Kwang-soo/hereafter WMIT), the largest exhibition in the Middle East, will be held at the Dubai World Trade Center for a total of 4 days fromJanuary 24 to 27 next year, "Arab Health 2022" to form ...
2022-01-20 13:00
1721
Award: Boehringer Ingelheim is Global Top Employer 2022
* Boehringer Ingelheim advances to one of eleven global top employers worldwide * This is the second consecutive year for the global certification, and the fourth consecutive year for the certification inPhilippines * High scores in values, ethics and integrity serve as a driver for a strong...
2022-01-20 08:00
1671
Award: Boehringer Ingelheim is Global Top Employer 2022
* Boehringer Ingelheim advances to one of eleven global top employers worldwide * This is the second consecutive year for the global certification, and the second consecutive year for the certification inAustralia & New Zealand * High scores in values, ethics and integrity serve as a driver ...
2022-01-20 08:00
1755
Award: Boehringer Ingelheim is Global Top Employer 2022
* Boehringer Ingelheim advances to one of eleven global top employers worldwide * This is the second consecutive year for the global certification, and the fourth consecutive year for the certification inMalaysia * High scores in values, ethics and integrity serve as a driver for a strong c...
2022-01-20 08:00
1793
Award: Boehringer Ingelheim is Global Top Employer 2022
* Boehringer Ingelheim advances to one of eleven global top employers worldwide * This is the second consecutive year for the global certification, and the fifth consecutive year for the certification inSingapore * High scores in values, ethics and integrity serve as a driver for a strong c...
2022-01-20 08:00
1676
Award: Boehringer Ingelheim is Global Top Employer 2022
* Boehringer Ingelheim advances to one of eleven global top employers worldwide * This is the second consecutive year for the global certification, and the third consecutive year for the certification inVietnam * High scores in values, ethics and integrity serve as a driver for a strong cor...
2022-01-20 08:00
5227
Award: Boehringer Ingelheim is Global Top Employer 2022
* Boehringer Ingelheim advances to one of eleven global top employers worldwide * This is the second consecutive year for the global certification, and the fourth consecutive year for the certification inThailand * High scores in values, ethics and integrity serve as a driver for a strong c...
2022-01-20 08:00
2136
Award: Boehringer Ingelheim is Global Top Employer 2022
* Boehringer Ingelheim advances to one of eleven global top employers worldwide * This is the second consecutive year for the global certification, and the third consecutive year for the certification inIndonesia * High scores in values, ethics and integrity serve as a driver for a strong c...
2022-01-20 08:00
2427
"JEWISH NOBEL" AWARDED TO PFIZER CEO ALBERT BOURLA
Genesis Prize Chairman highlights immense role of Jewish scientists and doctors in combatting the pandemic: "A very proud moment for the entire Jewish community" JERUSALEM, Jan. 20, 2022 /PRNewswire/ -- Today, The Genesis Prize Foundation announced Dr.Albert Bourla, Chairman and CEO of Pfizer,...
2022-01-20 06:13
1737
Week's Top Stories
Most Reposted
LINKDOOD Breaks Language Barriers, Ushering a New Era for Cross-Border Romance
[Picked up by 326 media titles]
2024-04-29 06:00
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 287 media titles]
2024-04-30 10:11
INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
[Picked up by 274 media titles]
2024-04-24 17:09
Puyuan Fashion Resort 2024: A Grand Unveiling of Global Trends and Local Heritage
[Picked up by 269 media titles]
2024-04-28 09:39
Introducing Wacom Movink: The first OLED pen display, and the thinnest and lightest Wacom pen display ever
[Picked up by 268 media titles]
2024-04-24 13:00
Most Read
Automation Anywhere Appoints Tim McDonough as Chief Marketing Officer to Drive Global Awareness and Growth for the Leader in AI-Powered Automation
2024-04-24 03:57
7873
INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
2024-04-24 17:09
6964
Introducing Wacom Movink: The first OLED pen display, and the thinnest and lightest Wacom pen display ever
2024-04-24 13:00
4257
Scienjoy Holding Corporation Reports Fiscal Year 2023 Financial Results
2024-04-27 04:30
2908